AI summary

65% confidence

Microbial fuel cells were used to remove hepatitis B virus surface and core antigens from human urine, with a 98.6% reduction in surface antigen and a 41.0% reduction in core antigen.

Generated by MESSAI extraction pipeline · review against source PDF

Generic MFCRepresentative model
Click to animate flow
loading 3D model…

Representative MFC — matched on the paper’s system type only, not its reactor or geometry.

Extraction

Reported parameters

1 extracted value

View extracted values

Open in lab for full controls, parameter editing, and template overlays.

Open in lab →

What they did

System
MFC

What worked

No outcome metrics extracted yet.

Abstract

Abstract Microbial electrochemical technology is emerging as an alternative way of treating waste and converting this directly to electricity. Intensive research on these systems is ongoing but it currently lacks the evaluation of possible environmental transmission of enteric viruses originating from the waste stream. In this study, for the first time we investigated this aspect by assessing the removal efficiency of hepatitis B core and surface antigens in cascades of continuous flow microbial fuel cells. The log-reduction (LR) of surface antigen (HBsAg) reached a maximum value of 1.86 ± 0.20 (98.6% reduction), which was similar to the open circuit control and degraded regardless of the recorded current. Core antigen (HBcAg) was much more resistant to treatment and the maximal LR was equal to 0.229 ± 0.028 (41.0% reduction). The highest LR rate observed for HBsAg was 4.66 ± 0.19 h −1 and for HBcAg 0.10 ± 0.01 h −1 . Regression analysis revealed correlation between hydraulic retention time, power and redox potential on inactivation efficiency, also indicating electroactive behaviour of biofilm in open circuit control through the snorkel-effect. The results indicate that microbial electrochemical technologies may be successfully applied to reduce the risk of environmental transmission of hepatitis B virus but also open up the possibility of testing other viruses for wider implementation.

Key findings

  • [object Object]
  • [object Object]
  • [object Object]

Keywords

HBcAgHBsAgVirologyHepatitis B virusUrineAntigen

Identifiers

Journal
Scientific Reports
Year
2019